Approval · Notice of Compliance 3536 · 2003
BEXTRA: Notice of Compliance 3536
Issued September 11, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3536
- Date
- September 11, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Analgesic anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BEXTRA | 02246621 | — |
| BEXTRA | 02246622 | — |
| BEXTRA | 02246623 | — |
Medicinal ingredients
- VALDECOXIB 10 MG per TAB
- VALDECOXIB 20 MG per TAB
- VALDECOXIB 40 MG per TAB